Published in Br J Pharmacol on May 01, 1995
The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors. Br J Pharmacol (2013) 5.74
Orphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1. Br J Pharmacol (2000) 1.78
Endothelin signalling in arterial smooth muscle is tightly regulated by G protein-coupled receptor kinase 2. Cardiovasc Res (2009) 1.70
Endothelin-2, the forgotten isoform: emerging role in the cardiovascular system, ovarian development, immunology and cancer. Br J Pharmacol (2013) 1.03
Plasticity of contractile endothelin-B receptors in human arteries after organ culture. Br J Pharmacol (1996) 0.99
Role of ERK/MAPK in endothelin receptor signaling in human aortic smooth muscle cells. BMC Cell Biol (2009) 0.98
Sex differences in endothelin-1-mediated vasoconstrictor tone in middle-aged and older adults. Am J Physiol Regul Integr Comp Physiol (2009) 0.95
Endothelin. Pharmacol Rev (2016) 0.95
EndothelinB receptor-mediated contraction in human pulmonary resistance arteries. Br J Pharmacol (1996) 0.92
Endothelin receptors in human coronary artery and aorta. Br J Pharmacol (1996) 0.92
Concentration-related effects of nitric oxide and endothelin-1 on human trabecular meshwork cell contractility. Exp Eye Res (2013) 0.92
Evidence that ET-1, but not ET-3 and S6b, ET(A)-receptor mediated contractions in isolated rat mesenteric arteries are modulated by co-activation of ET(B) receptors. Br J Pharmacol (2001) 0.91
Physiological antagonism of endothelin-1 in human conductance and resistance coronary artery. Br J Pharmacol (2001) 0.89
Characterization of the endothelin receptor selective agonist, BQ3020 and antagonists BQ123, FR139317, BQ788, 50235, Ro462005 and bosentan in the heart. Br J Pharmacol (1996) 0.89
The increase in human plasma immunoreactive endothelin but not big endothelin-1 or its C-terminal fragment induced by systemic administration of the endothelin antagonist TAK-044. Br J Pharmacol (1996) 0.89
Targeting tumor perfusion and oxygenation to improve the outcome of anticancer therapy. Front Pharmacol (2012) 0.88
Endothelin receptors and their antagonists. Semin Nephrol (2015) 0.87
Nitric oxide-mediated modulation of the endothelin-1 signalling pathway in the human cardiovascular system. Br J Pharmacol (2001) 0.87
Vasoconstrictor activity of novel endothelin peptide, ET-1(1 - 31), in human mammary and coronary arteries in vitro. Br J Pharmacol (2001) 0.86
Failure of BQ123, a more potent antagonist of sarafotoxin 6b than of endothelin-1, to distinguish between these agonists in binding experiments. Br J Pharmacol (1996) 0.86
Characterization of the binding of endothelin ETB selective ligands in human and rat heart. Br J Pharmacol (1996) 0.85
Heart ischaemia-reperfusion induces local up-regulation of vasoconstrictor endothelin ETB receptors in rat coronary arteries downstream of occlusion. Br J Pharmacol (2014) 0.84
Endothelin receptor expression and pharmacology in human saphenous vein graft. Br J Pharmacol (1999) 0.84
Endogenous endothelin stimulates cardiac sympathetic afferents during ischaemia. J Physiol (2010) 0.84
Smooth muscle specific disruption of the endothelin-A receptor in mice reduces arterial pressure, and vascular reactivity and affects vascular development. Life Sci (2014) 0.83
Phosphoramidon inhibition of the in vivo conversion of big endothelin-1 to endothelin-1 in the human forearm. Br J Pharmacol (1995) 0.83
Metabolic and vascular actions of endothelin-1 are inhibited by insulin-mediated vasodilation in perfused rat hindlimb muscle. Br J Pharmacol (2005) 0.81
Characterization of endothelin receptors in the human umbilical artery and vein. Br J Pharmacol (1996) 0.81
Modulation of endothelin receptors in the failing right ventricle of the heart and vasculature of the lung in human pulmonary arterial hypertension. Life Sci (2014) 0.79
Up-regulation of endothelin type B receptors in the human internal mammary artery in culture is dependent on protein kinase C and mitogen-activated kinase signaling pathways. BMC Cardiovasc Disord (2008) 0.78
The mechanism of cryoinjury: In vitro studies on human internal mammary arteries. Br J Pharmacol (2000) 0.77
Air Pollution-Induced Vascular Dysfunction: Potential Role of Endothelin-1 (ET-1) System. Cardiovasc Toxicol (2016) 0.76
Enhanced expressions of endothelin-converting enzyme and endothelin receptors in human colonic tissues of Crohn's disease. J Clin Biochem Nutr (2008) 0.75
Hypoxic Pulmonary Vasoconstriction in Humans: Tale or Myth. Open Cardiovasc Med J (2017) 0.75
Evidence for biased agonists and antagonists at the endothelin receptors. Life Sci (2016) 0.75
Endothelin-1 impairs coronary arteriolar dilation: Role of p38 kinase-mediated superoxide production from NADPH oxidase. J Mol Cell Cardiol (2015) 0.75
Translational value of mechanical and vasomotor properties of mouse isolated mesenteric resistance-sized arteries. Pharmacol Res Perspect (2015) 0.75
Selective endothelin A receptor antagonism with sitaxentan reduces neointimal lesion size in a mouse model of intraluminal injury. Br J Pharmacol (2015) 0.75
Some quantitative uses of drug antagonists. Br J Pharmacol Chemother (1959) 41.90
A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature (1988) 27.60
The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci U S A (1989) 7.41
Cloning and expression of a cDNA encoding an endothelin receptor. Nature (1991) 7.26
Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature (1991) 7.11
Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels. Circulation (1994) 2.69
Molecular characterization of endothelin receptors. Trends Pharmacol Sci (1992) 2.04
Is endothelin-induced vasoconstriction mediated only by ETA receptors in humans? Trends Pharmacol Sci (1994) 1.79
Autoradiographical localization of binding sites for porcine [125I]endothelin-1 in humans, pigs, and rats: functional relevance in humans. J Cardiovasc Pharmacol (1989) 1.57
Endothelin in human congestive heart failure. Circulation (1994) 1.56
Heterogeneity of endothelin-sarafotoxin receptors mediating contraction of pig coronary artery. Br J Pharmacol (1992) 1.55
Mediation via different receptors of the vasoconstrictor effects of endothelins and sarafotoxins in the systemic circulation and renal vasculature of the anaesthetized rat. Br J Pharmacol (1993) 1.51
Endothelin ETA and ETB mRNA and receptors expressed by smooth muscle in the human vasculature: majority of the ETA sub-type. Br J Pharmacol (1995) 1.48
Interaction between endothelin-1 and endothelium-derived relaxing factor in human arteries and veins. Circ Res (1990) 1.37
Plasma endothelin levels in patients with acute renal failure. N Engl J Med (1989) 1.36
Endothelin receptor subtypes in human and guinea-pig pulmonary tissues. Br J Pharmacol (1993) 1.33
Novel ligands BQ123 and BQ3020 characterize endothelin receptor subtypes ETA and ETB in human kidney. Kidney Int (1993) 1.22
Characterization of two new ETB selective radioligands, [125I]-BQ3020 and [125I]-[Ala1,3,11,15]ET-1 in human heart. Br J Pharmacol (1992) 1.17
A specific endothelin subtype A receptor antagonist protects against injury in renal disease progression. Kidney Int (1993) 1.17
In vitro biological profile of a highly potent novel endothelin (ET) antagonist BQ-123 selective for the ETA receptor. J Cardiovasc Pharmacol (1992) 1.15
Endothelin receptors mediating functional responses in human small arteries and veins. Br J Pharmacol (1994) 1.14
Endothelin receptor subtypes in human versus rabbit pulmonary arteries. J Appl Physiol (1985) (1994) 1.10
Evidence for heterogeneity of endothelin receptor distribution in human coronary artery. Br J Pharmacol (1993) 1.04
Oral yohimbine increases blood pressure and sympathetic nervous outflow in hypertensive patients. J Cardiovasc Pharmacol (1993) 1.02
Vasoconstrictor endothelin receptors characterized in human renal artery and vein in vitro. Br J Pharmacol (1994) 1.01
Retracted An endothelin B receptor-selective antagonist: IRL 1038, [Cys11-Cys15]-endothelin-1(11-21) FEBS Lett (1992) 0.99
Endothelin- and neuropeptide Y-induced vasoconstriction of human epicardial coronary arteries in vitro. Br J Pharmacol (1989) 0.99
Human saphenous vein contains both endothelin ETA and ETB contractile receptors. Eur J Pharmacol (1994) 0.97
BQ-123, a peptidic endothelin ETA receptor antagonist, prevents the early cerebral vasospasm following subarachnoid hemorrhage after intracisternal but not intravenous injection. Life Sci (1993) 0.96
Occurrence, specific binding sites and functional effects of endothelin in human cardiopulmonary tissue. Eur J Pharmacol (1990) 0.96
Heterogeneity of endothelin/sarafotoxin receptors mediating contraction of the human isolated saphenous vein. Eur J Pharmacol (1993) 0.96
Endothelin is a potent constrictor of human vessels used in coronary revascularization surgery. Eur J Pharmacol (1990) 0.94
Endothelin receptor antagonism is protective in in vivo acute cyclosporine toxicity. Kidney Int (1992) 0.94
Endothelin-1 in primary pulmonary hypertension and the Eisenmenger syndrome. Am J Cardiol (1993) 0.94
Human vascular responses to endothelin-1: observations in vivo and in vitro. J Cardiovasc Pharmacol (1989) 0.92
Systemic and renal effect of intravenous infusion of endothelin-1 in healthy human volunteers. Am J Physiol (1994) 0.92
Endothelins and sarafotoxins: receptor heterogeneity. Int J Biochem (1994) 0.90
The endothelin-1 receptor antagonist BQ-123 reduces infarct size in a canine model of coronary occlusion and reperfusion. Cardiovasc Res (1993) 0.90
Localization of endothelin immunoreactivity and demonstration of constrictory endothelin-A receptors in human coronary arteries and veins. J Cardiovasc Pharmacol (1994) 0.89
A novel endothelin ETA receptor antagonist, BQ-485, and its preventive effect on experimental cerebral vasospasm in dogs. Biochem Biophys Res Commun (1993) 0.87
Different endothelin receptors involved in endothelin-1- and sarafotoxin S6B-induced contractions of the human isolated coronary artery. Br J Pharmacol (1994) 0.87
Characterization of contractile responses to endothelin in human cerebral arteries: implications for cerebral vasospasm. Neurosurgery (1990) 0.85
An endothelin B receptor-selective antagonist: IRL 1038, [Cys11- Cys15]-endothelin-1(11-21) FEBS Lett (1994) 0.85
Effect of endothelin on normal and diseased human coronary arteries. Eur J Clin Invest (1992) 0.85
Endothelium-dependent modulation of responses to endothelin-I in human veins. Clin Sci (Lond) (1993) 0.84
Increased endothelin level after cyclosporine therapy. Ann Intern Med (1991) 0.84
Myricerone caffeoyl ester (50-235) is a non-peptide antagonist selective for human ETA receptors. J Hypertens (1994) 0.81
Mechanisms of the biphasic responses to endothelin-3 in dog coronary arteries. Br J Pharmacol (1992) 0.81
Functional and autoradiographic studies of endothelin-1 and endothelin-2 in human bronchi, pulmonary arteries, and airway parasympathetic ganglia. J Cardiovasc Pharmacol (1991) 0.79
Comparative effects of endothelin (ET-1) and U46619 on human saphenous vein and gastroepiploic artery, sources of human autologous grafts. Mol Cell Biochem (1992) 0.79
Effects of calcium- and ETA-receptor antagonists on endothelin-induced vasoconstriction and levels of endothelin in the human internal mammary artery. Clin Exp Pharmacol Physiol (1994) 0.79
Reversal of endothelin-1-induced vasoconstriction by nifedipine in human resistance vessels in vivo in healthy subjects. Am J Cardiol (1992) 0.77
Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation (2002) 4.43
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
Orphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1. Br J Pharmacol (2000) 1.78
Characterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium. Circ Res (1993) 1.56
[(125)I]-(Pyr(1))Apelin-13 is a novel radioligand for localizing the APJ orphan receptor in human and rat tissues with evidence for a vasoconstrictor role in man. Br J Pharmacol (2001) 1.40
Chemokine receptor CCR5: from AIDS to atherosclerosis. Br J Pharmacol (2011) 1.29
Novel ligands BQ123 and BQ3020 characterize endothelin receptor subtypes ETA and ETB in human kidney. Kidney Int (1993) 1.22
Characterization of two new ETB selective radioligands, [125I]-BQ3020 and [125I]-[Ala1,3,11,15]ET-1 in human heart. Br J Pharmacol (1992) 1.17
Effects of an ET1-receptor antagonist, FR139317, on regional haemodynamic responses to endothelin-1 and [Ala11,15]Ac-endothelin-1 (6-21) in conscious rats. Br J Pharmacol (1994) 1.15
Endothelin-1 mRNA is widely expressed in porcine and human tissues. J Clin Invest (1990) 1.13
[125I-His(9)]-ghrelin, a novel radioligand for localizing GHS orphan receptors in human and rat tissue: up-regulation of receptors with athersclerosis. Br J Pharmacol (2001) 1.11
Kisspeptins: a multifunctional peptide system with a role in reproduction, cancer and the cardiovascular system. Br J Pharmacol (2007) 1.11
Depressor and regionally-selective vasodilator effects of human and rat urotensin II in conscious rats. Br J Pharmacol (2001) 1.10
Endothelin peptide and receptors in human atherosclerotic coronary artery and aorta. Circ Res (1996) 1.04
Vasoconstrictor endothelin receptors characterized in human renal artery and vein in vitro. Br J Pharmacol (1994) 1.01
Effect of in vivo fetal infusion of dexamethasone at 0.75 GA on fetal ovine resistance artery responses to ET-1. Am J Physiol Regul Integr Comp Physiol (2001) 1.00
Presence of messenger ribonucleic acid for endothelin-1, endothelin-2, and endothelin-3 in human endometrium and a change in the ratio of ETA and ETB receptor subtype across the menstrual cycle. J Clin Endocrinol Metab (1992) 1.00
Secretory pathways in endothelin synthesis. Br J Pharmacol (1999) 0.98
Human endothelial cell storage granules: a novel intracellular site for isoforms of the endothelin-converting enzyme. Circ Res (1998) 0.97
Anatomical localization and pharmacological activity of mature endothelins and their precursors in human vascular tissue. J Hypertens (1992) 0.95
Evidence using immunoelectron microscopy for regulated and constitutive pathways in the transport and release of endothelin. J Cardiovasc Pharmacol (1998) 0.95
Thromboxane receptor density is increased in human cardiovascular disease with evidence for inhibition at therapeutic concentrations by the AT(1) receptor antagonist losartan. Br J Pharmacol (2001) 0.93
Emerging pharmacology and physiology of neuromedin U and the structurally related peptide neuromedin S. Br J Pharmacol (2009) 0.93
Evaluation of translocator protein quantification as a tool for characterising macrophage burden in human carotid atherosclerosis. Atherosclerosis (2009) 0.93
Comparison of the vasoconstrictor effects of rizatriptan and sumatriptan in human isolated cranial arteries: immunohistological demonstration of the involvement of 5-HT1B-receptors. Br J Clin Pharmacol (1998) 0.93
Endothelin receptors in human coronary artery and aorta. Br J Pharmacol (1996) 0.92
Endothelin converting enzyme (ECE) activity in human vascular smooth muscle. Br J Pharmacol (1997) 0.90
Secretion of endothelin-1 and endothelin-3 by human cultured vascular smooth muscle cells. Br J Pharmacol (1995) 0.89
Endothelin receptor subtypes and their functional relevance in human small coronary arteries. Br J Pharmacol (1998) 0.89
Physiological antagonism of endothelin-1 in human conductance and resistance coronary artery. Br J Pharmacol (2001) 0.89
Characterization of the endothelin receptor selective agonist, BQ3020 and antagonists BQ123, FR139317, BQ788, 50235, Ro462005 and bosentan in the heart. Br J Pharmacol (1996) 0.89
The increase in human plasma immunoreactive endothelin but not big endothelin-1 or its C-terminal fragment induced by systemic administration of the endothelin antagonist TAK-044. Br J Pharmacol (1996) 0.89
Endothelial cell-specific ETB receptor knockout: autoradiographic and histological characterisation and crucial role in the clearance of endothelin-1. Can J Physiol Pharmacol (2010) 0.88
Alternatively spliced mRNAs for human endothelin-2 and their tissue distribution. Biochem Biophys Res Commun (1993) 0.88
Evidence for intracellular endothelin-converting enzyme-2 expression in cultured human vascular endothelial cells. Circ Res (1999) 0.88
Endothelin receptor antagonism in patients with chronic heart failure. Cardiovasc Res (2000) 0.87
Blockade and reversal of endothelin-induced constriction in pial arteries from human brain. Stroke (1999) 0.87
A quantitative 'in-situ' hybridization method using computer-assisted image analysis. Validation and measurement of atrial-natriuretic-factor mRNA in the rat heart. Biochem J (1989) 0.87
Characterization of endothelin isoforms in human heart: endothelin-2 demonstrated. J Cardiovasc Pharmacol (1993) 0.87
Nitric oxide-mediated modulation of the endothelin-1 signalling pathway in the human cardiovascular system. Br J Pharmacol (2001) 0.87
Failure of BQ123, a more potent antagonist of sarafotoxin 6b than of endothelin-1, to distinguish between these agonists in binding experiments. Br J Pharmacol (1996) 0.86
Vasoconstrictor activity of novel endothelin peptide, ET-1(1 - 31), in human mammary and coronary arteries in vitro. Br J Pharmacol (2001) 0.86
Selectivity of [125I]-PD151242 for human, rat and porcine endothelin ETA receptors in the heart. Br J Pharmacol (1995) 0.86
Affinity and selectivity of PD156707, a novel nonpeptide endothelin antagonist, for human ET(A) and ET(B) receptors. J Pharmacol Exp Ther (1997) 0.86
Endothelin@25 - new agonists, antagonists, inhibitors and emerging research frontiers: IUPHAR Review 12. Br J Pharmacol (2014) 0.85
Expression of endothelin peptides and mRNA in the human heart. Clin Sci (Lond) (1996) 0.85
Discovery of recently adopted orphan receptors for apelin, urotensin II, and ghrelin identified using novel radioligands and functional role in the human cardiovascular system. Can J Physiol Pharmacol (2002) 0.85
Characterization of the binding of endothelin ETB selective ligands in human and rat heart. Br J Pharmacol (1996) 0.85
Endothelin ETA receptor expression in human cerebrovascular smooth muscle cells. Br J Pharmacol (1995) 0.85
Localization of endothelin peptides in human kidney. Kidney Int (1996) 0.84
Quantification of mRNA in human tissue using fluorescent nested reverse-transcriptase polymerase chain reaction. Anal Biochem (1994) 0.84
Endothelin receptor expression and pharmacology in human saphenous vein graft. Br J Pharmacol (1999) 0.84
Endothelin expression in the uterus. J Steroid Biochem Mol Biol (1995) 0.84
Localization of endothelin receptors in human uterus throughout the menstrual cycle. Mol Hum Reprod (1996) 0.84
Epidermal growth factor in human endometrium: proliferative effects in culture and immunocytochemical localization in normal and endometriotic tissues. Hum Reprod (1991) 0.84
Phosphoramidon inhibition of the in vivo conversion of big endothelin-1 to endothelin-1 in the human forearm. Br J Pharmacol (1995) 0.83
Characterization of endothelin receptors in human brain cortex, gliomas, and meningiomas. J Cardiovasc Pharmacol (1995) 0.83
Endothelin: progress in pharmacology and physiology. Trends Pharmacol Sci (1993) 0.83
Expression of endothelin(A) receptors in human gliomas and meningiomas, with high affinity for the selective antagonist PD156707. Neurosurgery (1998) 0.83
Relative contribution of endothelin A and endothelin B receptors to vasoconstriction in small arteries from human heart and brain. J Cardiovasc Pharmacol (1998) 0.82
Differential distribution of endothelin receptor subtypes in placentae from normal and growth-restricted pregnancies. Placenta (1997) 0.82
Effects of phosphoramidon and pepstatin A on the secretion of endothelin-1 and big endothelin-1 by human umbilical vein endothelial cells: measurement by two-site enzyme-linked immunosorbent assays. Clin Sci (Lond) (1994) 0.82
Human kidney: endothelin isoforms detected by HPLC with radioimmunoassay and receptor subtypes detected using ligands BQ123 and BQ3020. J Cardiovasc Pharmacol (1993) 0.82
Regulation of endothelin receptor expression in vascular smooth-muscle cells. J Cardiovasc Pharmacol (1995) 0.81
ETA and ETB endothelin receptors in human myometrium characterized by the subtype selective ligands BQ123, BQ3020, FR139317 and PD151242. J Endocrinol (1995) 0.81
Maternal dexamethasone increases endothelin-1 sensitivity and endothelin a receptor expression in ovine foetal placental arteries. Placenta (2003) 0.81
Myricerone caffeoyl ester (50-235) is a non-peptide antagonist selective for human ETA receptors. J Hypertens (1994) 0.81
Endothelin-like immunoreactivity in human endometrium. J Reprod Fertil (1992) 0.81
Localization of immunoreactive endothelin and proendothelin in the human lung. Pulm Pharmacol (1992) 0.81
Endothelin-A-receptors in human aorta and pulmonary arteries are downregulated in patients with cardiovascular disease: an adaptive response to increased levels of endothelin-1? J Cardiovasc Pharmacol (2000) 0.81
Increased response to big endothelin-1 in atherosclerotic human coronary artery: functional evidence for up-regulation of endothelin-converting enzyme activity in disease. Br J Pharmacol (1998) 0.80
Characterization of the snake venom ligand [125I]-DNP binding to natriuretic peptide receptor-A in human artery and potent DNP mediated vasodilatation. Br J Pharmacol (2006) 0.80
Identification of endothelin-1, endothelin-2 and endothelin-3 in human endometrium. J Reprod Fertil (1993) 0.80
The endothelin peptides ET-1, ET-2, ET-3 and sarafotoxin S6b are co-mitogenic with platelet-derived growth factor for vascular smooth muscle cells. Atherosclerosis (1990) 0.79
No alteration in vasoconstrictor endothelin-B-receptor density or function in human coronary artery disease. J Cardiovasc Pharmacol (2000) 0.79
Delineation of endothelin receptors in human left ventricular smooth-muscle cells. J Cardiovasc Pharmacol (1995) 0.78
Changes in ET(A)-, AT1- and AT2-receptors in the phenotypically transformed intimal smooth muscle layer of human atherosclerotic coronary arteries. J Cardiovasc Pharmacol (2000) 0.78
Measurement of C-terminal fragment of big endothelin-1: a novel method for assessing the generation of endothelin-1 in humans. J Cardiovasc Pharmacol (1995) 0.78
Endothelin-2 mRNA splice variants detected by RT-PCR in cultured human vascular smooth muscle and endothelial cells. J Cardiovasc Pharmacol (1993) 0.78
Localization and endogenous concentration of endothelin-like immunoreactivity in human placenta. J Endocrinol (1991) 0.78
Endothelin peptide and converting enzymes in human endothelium. J Cardiovasc Pharmacol (1998) 0.77
Endothelin and the human kidney: a potential target for new drugs. Nephrol Dial Transplant (1994) 0.77
Novel nitric oxide donors reverse endothelin-1-mediated constriction in human blood vessels. J Cardiovasc Pharmacol (2000) 0.77
Distribution of endothelin receptors in atherosclerotic human coronary arteries. J Cardiovasc Pharmacol (1995) 0.77
PD156707: a potent antagonist of endothelin-1 in human diseased coronary arteries and vein grafts. J Cardiovasc Pharmacol (1998) 0.77
Syntheses of the first endothelin-A- and -B-selective radioligands for positron emission tomography. J Cardiovasc Pharmacol (2000) 0.77
Biogenic amines in the brain of the honeybee, Apis mellifera. Cell Tissue Res (1983) 0.77
Endothelin-1 stimulates prostaglandin F2 alpha release from human endometrium. Prostaglandins Leukot Essent Fatty Acids (1991) 0.76
Characterization of endothelin receptors in the human pulmonary vasculature using bosentan, SB209670, and 97-139. J Cardiovasc Pharmacol (1995) 0.76
Detection of endothelin receptors in human coronary artery vascular smooth muscle cells but not endothelial cells by using electron microscope autoradiography. J Cardiovasc Pharmacol (1997) 0.76
Characterization of peptide and nonpeptide antagonists in human kidney. J Cardiovasc Pharmacol (1995) 0.76
The haemodynamic effects of iodinated water soluble radiographic contrast media: a review. Eur J Radiol (1998) 0.76
In vitro enzymatic processing of radiolabelled big ET-1 in human kidney. Biochem Pharmacol (1998) 0.76
Comparative quantification of endothelin receptor mRNA in human kidney: new tools for direct investigation of human tissue. J Cardiovasc Pharmacol (1995) 0.76
Cerebellar neurons and glia respond differentially to endothelins and sarafotoxin S6b. Brain Res (1992) 0.76
Atrial natriuretic factor mRNA and binding sites in the adrenal gland. Biochem J (1990) 0.76